Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael P Castro
Observed names:
M. Castro,
Michael Castro,
Michael P. Castro
Institutions:
Beverly Hills Cancer Center,
Annexon Biosciences (United States)
Observed institutions:
University of Hawaiʻi at Mānoa,
Cellworks Research (India),
Center for Personalized Cancer Treatment,
Beverly Hills Cancer Center,
Annexon Biosciences (United States),
Glens Falls Hospital,
Caris Life Sciences (United States),
Surrozen, Inc. (United States)
show all 8
ORCID:
0000-0003-0421-1027
Observed ORCID:
0000-0003-0421-1027
OpenAlex ID:
A5014677392
Apocrine carcinoma of the breast: a comprehensive review.
2013
·
Semir Vranic
, Fernando Schmitt
, et al.
·
PubMed
·
108
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
2024
·
Pauline Latzer
, Henning Zelba
, et al.
·
Nature Communications
·
76
Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma
1999
·
Michael P. Castro
, Jean VanAuken
, et al.
·
Cancer
·
63
Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: A case report
1998
·
Michael P. Castro
·
Cancer
·
37
PDF
Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
2015
·
Michael P. Castro
, Neal Goldstein
·
Journal for ImmunoTherapy of Cancer
·
36
PDF
Thymidine Rescue: An Antidote for Pemetrexed-Related Toxicity in the Setting of Acute Renal Failure
2003
·
Michael Castro
·
Journal of Clinical Oncology
·
17
Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease
2015
·
Michael P. Castro
, Bradford P. Whitcomb
, et al.
·
Gynecologic Oncology Research and Practice
·
12
PDF
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
2021
·
Michael Castro
, Anusha Pampana
, et al.
·
Journal of Neuro-Oncology
·
11
PDF
Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma
2001
·
Michael P. Castro
, Tom J. McDonald
, et al.
·
Cancer
·
11
PDF
Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
2016
·
Michael Castro
, Koah Vierkoetter
, et al.
·
Case Reports in Oncology
·
10
Metastatic Cancer of Cowper's Gland: A Rare Cancer Managed Successfully by Molecular Profiling
2014
·
Charles E. Myers
, Zoran Gatalica
, et al.
·
Case Reports in Oncology
·
10
PDF
The Simpleton’s Error in Drug Development
2002
·
Michael Castro
·
Journal of Clinical Oncology
·
10
Resisting a Fundamentalist Policy
2005
·
Michael Castro
·
Journal of Clinical Oncology
·
9
PDF
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination
2025
·
Henning Zelba
, Borong Shao
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database
2024
·
Michael P Castro
, Jameson Quinn
, et al.
·
Neuro-Oncology Practice
·
7
Major histocompatibility complex class 1 (MHC1) loss among patients with glioblastoma (GBM).
2020
·
Michael Castro
, Bence Sipos
, et al.
·
Journal of Clinical Oncology
·
7
Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy—a case report
2022
·
Michael P. Castro
, Negar Khanlou
, et al.
·
Annals of Translational Medicine
·
6
PDF
Drug efflux pump expression in 50,000 molecularly-profiled cancer patients.
2015
·
Rebecca Feldman
, Brian L. Abbott
, et al.
·
Journal of Clinical Oncology
·
6
Frequency of BRCA mutations and co-occurring alterations in prostate cancer.
2016
·
Charles E. Myers
, Rebecca Feldman
, et al.
·
Journal of Clinical Oncology
·
5
Network targeting combination therapy of synthetic lethal vulnerabilities in 9p21-deficient glioblastoma: A case report
2023
·
Michael P Castro
, Kristin Dittmar
·
Neuro-Oncology Advances
·
2
PDF
Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report
2023
·
Michael P. Castro
, Bence Sipos
, et al.
·
Frontiers in Oncology
·
2
PDF
Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.
2021
·
Patrick Y. Wen
, Michael Castro
, et al.
·
Journal of Clinical Oncology
·
2
Prediction of Clinical Response for Frontline Treatment of Acute Myeloid Leukemia (AML) Patients Using the Cellworks Omics Biology Model (CBM): Mycare-021-02
2020
·
Michael Castro
, Prashant Ramachandran Nair
, et al.
·
Blood
·
2
The use of rituximab to manage B cell-mediated autoimmune thrombocytopenia (AITP) during concurrent program death ligand-1 (PD-L1) immunotherapy.
2016
·
Michael Castro
·
Journal of Clinical Oncology
·
2
Abstract 4716: Functional precision medicine: Uncovering high actionability in rare cancers beyond genomics
2025
·
Rachele Rosati
, Payel Chatterjee
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
69
Citation count:
466
H-index:
10
I10-index:
12
Year
Topic
Type